Status: current, Defined. Date: 31-Oct 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 686301000036110 | amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 686311000036112 | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Is a | olmesartan + amlodipine + hydrochlorothiazide | true | Inferred relationship | Some | ||
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has intended active ingredient | amlodipine | true | Inferred relationship | Some | 1715472900 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has Australian BoSS | amlodipine | true | Inferred relationship | Some | 1715472900 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1121344676 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1121344676 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has intended active ingredient | olmesartan | true | Inferred relationship | Some | 1130741443 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has Australian BoSS | olmesartan medoxomil | true | Inferred relationship | Some | 1130741443 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1715472901 | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Is a | olmesartan medoxomil 20 mg + amlodipine 5 mg tablet | true | Inferred relationship | Some | ||
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Is a | olmesartan medoxomil 20 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olmesartan/Amlodipine/HCTZ 20/5/12.5 (Apo) tablet | Is a | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | |
| Olmekar HCT 20/5/12.5 tablet | Is a | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Is a | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | |
| Olamlo HCT 20/5/12.5 tablet | Is a | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | |
| Sevikar HCT 20/5/12.5 tablet | Is a | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 | has MPUU | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | 1 |
| olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 10 | has MPUU | True | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR